Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2016

01-08-2016 | Letter to the Editor

Vitamin D and obstructive sleep apnea: an unexplored relationship in PCOS patients

Authors: Daniela Leite de Oliveira, Rachel Gimenes Albuquerque, Camila Hirotsu

Published in: Endocrine | Issue 2/2016

Login to get access

Excerpt

To the Editor, …
Literature
1.
G. Muscogiuri, S. Palomba, M. Caggiano, D. Tafuri, A. Colao, F. Orio, Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome. Endocrine. (2015). doi:10.​1007/​s12020-015-0745-0
2.
D.E. McCarty, A.L. Chesson Jr., S.K. Jain, A.A. Marino, The link between vitamin D metabolism and sleep medicine. Sleep Med. Rev. 18, 311–319 (2014)CrossRefPubMed
3.
N.C. Bozkurt, E. Cakal, M. Sahin, E.C. Ozkaya, H. Firat, T. Delibasi, The relation of serum 25-hydroxy vitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41, 518–525 (2012)CrossRefPubMed
4.
D.A. Ehrmann, Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea. Steroids 77, 290–294 (2012)CrossRefPubMed
5.
R.B. Fogel, A. Malhotra, G. Pillar, S.D. Pittman, A. Dunaif, D.P. White, Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 86, 1175–1180 (2001)PubMed
6.
7.
K. Toulis, X. Tsekmekidou, E. Potolidis, T. Didangelos, A. Gotzamani-Psarrakou, P. Zebekakis, M. Daniilidis, J. Yovos, K. Kotsa, Thyroid autoimmunity in the context of type 2 diabetes mellitus: implications for vitamin D. Int. J. Endocrinol. 2015, 710363 (2015)CrossRefPubMedPubMedCentral
Metadata
Title
Vitamin D and obstructive sleep apnea: an unexplored relationship in PCOS patients
Authors
Daniela Leite de Oliveira
Rachel Gimenes Albuquerque
Camila Hirotsu
Publication date
01-08-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0904-y

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue

Endocrine Imaging

A large functioning parathyroid lipoadenoma

Original Article

Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP)

Original Article

Minimally invasive follicular thyroid carcinomas: prognostic factors

Endocrine Genetics/Epigenetics

AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience

Original Article

Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer

Original Article

MCM2 mediates progesterone-induced endometrial stromal cell proliferation and differentiation in mice
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits